Acute gastroenteritis and unilateral vision loss leading to a diagnosis of aquaporin-4-IgG seropositive neuromyelitis optica spectrum of disorders in a child: A case of atypical optic neuritis in the era of biomarkers
DOI:
https://doi.org/10.7196/SAMJ.2024.v114i6.1616Keywords:
Neuromyelitis optica spectrum of disorders, aquaporin-4 immunoglobulin G antibody, atypical optic neuritisAbstract
Neuromyelitis optica spectrum of disorders is a rare cause of optic neuritis in children. It is a critical diagnosis requiring urgent management, with delays carrying both life- and sight-threatening complications. Most of the published literature on this entity is in adult patients, with only a few case reports to guide management in the paediatric population. The purpose of this article is to shareour experience in the management of this condition in a child, and thus hopefully add to the limited body of knowledge currently available.
References
Tenembaum S, Yeh EA, Guthy-Jackson Foundation International Clinical Consortium (GJCF-ICC). Pediatric NMOSD: A review and position statement on approach to work-up and diagnosis. Front Pediatr 2020;8:339. Erratum in: Front Pediatr 2021;8:642203. https://doi.org/10.3389/fped.2020.00339
Chitnis T, Ness J, Krupp L, et al. Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report. Neurology 2016;86(3):245-252. https://doi.org/10.1212/ WNL.0000000000002283
Poisson K, Moeller K, Kristen S. Pediatric neuromyelitis optica spectrum disorder. Sem Pediatr Neurol 2023;46:101051. https://doi.org/10.1016/j.spen.2023.101051
Ferilli MAN, Paparella R, Morandini I, Papetti L, Figà Talamanca L, Ruscitto C, Ursitti F, Moavero R, Sforza G, Tarantino S, Proietti Checchi M, Vigevano F, Valeriani M. Pediatric neuromyelitis optica spectrum disorder: Case series and literature review. Life 2021;12(1):19. https://doi.org/10.3390/ life12010019
Dembinski K, Gieron-Korthals M, Martinez CR, Rodriguez L,. Neuromyelitis optica in Child: diagnostic and therapeutic challenges. Case Rep Pediatr 2013:124929. https://doi.org/10.1155/2013/124929
Paolilo RB, Paz JAD, Apóstolos-Pereira SL, Rimkus CM, Callegaro D, Sato DK. Neuromyelitis optica spectrum disorders: A review with a focus on children and adolescents. Arq Neuropsiquiatr. 2023;81(2):201-211. https://doi.org/10.1055/s-0043-1761432.
Harvery JP. Optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disorder- optic neuritis: a comprehensive review of diagnosis and treatment. Eye 2022;36:658. https://doi. org/10.1038/s41433-021-01457-6
Zhang Z, Zhou H, Liu X, Liu L, Shu S, Fang F. Identification of the clinical and neuroimaging characteristics in children with neuromyelitis optica spectrum disorders: a case series. Transl Pediatr. 2021 Oct;10(10):2459-2466. https://doi.org/10.21037/tp-21-370
Bulut E, Karakaya J, Salama S, Levy M, Huisman TAGM, Izbudak I. Brain MRI findings in pediatric-onset neuromyelitis optica spectrum disorder: Challenges in differentiation from acute disseminated encephalomyelitis. AJNR Am J Neuroradiol 2019;40(4):726-731. https://doi. org/10.3174/ajnr.A6003
Hamami A, Rkain M, Benhachem M, Ghannam A , Elouali A, Babakhoua, A. Neuromyelitis Optica Revealed by Headache in a Child: A Case Report. Open J Pediatr 2023;13:432-436. https://doi. org/10.4236/ojped.2023.133048
Das S, Mondal GP, Bhattacharya R, Ghosh KC, Das S, Pattem H. Clinico-epidemiological profile and outcome of pediatric neuromyelitis optica spectrum disorder at an eastern Indian tertiary care center. J Pediatr Neurosci 2023;17(4):277-284.
Lock Jane H, Newman,N Biousse, Valériea Peragallo J. Update on pediatric optic neuritis. Curr Opin Ophthalmol 2019;30(6):418-425. | https://doi.org/10.1097/ICU.0000000000000607
Jeffery AR, Buncic JR, J Pediatr Ophthalmol Strabismus 2013;33(5):223-229. https://doi. org/10.3928/0191-3913-19960901-05
Millichap, J.G. (2008) ‘Seroprevalence of neuromyelitis optica-IgG of childhood compared to adults. Pediatric Neurol Briefs 2008;22(2):14-15. https://doi.org/10.15844/pedneurbriefs-22-2-7
Paul F, Marignier R, Palace J, et al. International Delphi Consensus on the Management of AQP4-IgG+ NMOSD: Recommendations for eculizumab, inebilizumab, and satralizumab. Neurol Neuroimmunol Neuroinflamm 2023;10(4):e200124. https://doi.org/10.1212/NXI.0000000000200124
Sellner J, Boggild M, Clanet M, Hintzen RQ, Illes Z, Montalban X, Du Pasquier RA, Polman CH, Sorensen PS, Hemmer B. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol. 2010 Aug;17(8):1019-32. https://doi.org/10.1111/j.1468-
Wang Z, Yan Y. Immunopathogenesis in Myasthenia Gravis and Neuromyelitis Optica. Front Immunol. 2017 Dec 12;8:1785. https://doi.org/10.3389/fimmu.2017.01785.
Shastry DD, Olivier J, Cullen C. Neuromyelitis optica and other causes of demyelinating optic neuritis in children. S Afr Ophthalmol J 2021;16(2):2021. link.gale.com/apps/doc/A688764653/HRCA?u=ano n~84a7e6b9&sid=googleScholar&xid=c8105f8c (accessed 20 May 2024).
Downloads
Published
Issue
Section
License
Copyright (c) 2024 N Narainswami
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
